The prevalence and risk factors of drug resistant pulmonary tuberculosis investigated at one university hospital in Seoul

Tuberculosis and Respiratory Diseases

Volumn 58, Issue 3, 2005, Pages 243-247

  Kim, Do Kyun ^c   Kim, Mi Ok ^b   Kim, Tae Hyung ^a   Sohn, Jang Won ^a   Yoon, Ho Joo ^a   Shin, Dong Ho ^a   Park, Sung Soo ^a  

^a Hanyang University   (South Korea)

^b JeJu Medical School   (South Korea)

^c National Medical Center   (South Korea)

Author keywords

Drug resistance; Korea; Pulmonary tuberculosis treatment; Risk factor

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; KOREA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PREVALENCE; REVIEW; RISK FACTOR; TREATMENT FAILURE; UNIVERSITY HOSPITAL;

EID: 20344374682     PISSN: 03780066     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2005.58.3.243     Document Type: Review

References (14)

1. Report on the 7th tuberculosis prevalence survey in Korea. Ministry of health and welfare, Korean national tuberculosis association. P.1-180, 1996.
2. Hong YP. Tuberculosis in Korea-yesterday, today and tomorrow. Tuberc Respir Dis 1997;44:1-10.
3. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The 7th nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998;2:27-36.
4. Lew WJ. Tuberculosis situation in Korea. Tuberc Respir Dis 1999;46:301-10.
5. The annual report 2003, Korean tuberculosis surveillance system. Korea center for disease control and prevention, The Korean national tuberculosis association.
6. Lew WJ. Tuberculosis surveillance system in Korea. Tuberc Respir Dis 2000;48:298-307.
7. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21-43.
8. Lew WJ. Several problems of multi-drug resistant tuberculosis. Tuberc Respir Dis 2000;48(S1):33-38.
9. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for anti-tuberculosis drug resistance, 1994-97, WHO-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998;338 (23):1641-9.
10. Kim SJ, Bai GH, Hong YP. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997;1(4):302-8.
11. Dye C, Espinal MA, Watt CJ, Mbiaga G, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002;185(8):1197-202.
12. Kim SI, Park JM, Wie SH, Kim YR, Kang MW. The trend of antibiotics usage in Korea during 1981-1998. Korean J Infect Dis 2000;32(6):436-447.
13. Lee JH, Chang JH. Drug resistant tuberculosis in a tertiary referral teaching hospital of Korea. The Korean J Int Med 2001;16(3):173-179.
14. Welsh CH. Drug resistant tuberculosis after gastrectomy. Double jeopardy? Chest 1991;99(1):245-7.